Credential Qtrade Securities Inc. Bausch Health Companies Inc. Transaction History

Credential Qtrade Securities Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2025	SELL	$7.06 - $23.63 $145,866 - $488,219	-20,661 Closed	0 $0
Q1 2022 Jul 21, 2025	BUY	$21.6 - $27.79 $24,472 - $31,486	1,133 Added 5.8%	20,661 $472 Million
Q4 2021 Jul 21, 2025	SELL	$23.0 - $29.01 $29,417 - $37,103	-1,279 Reduced 6.15%	19,528 $540 Million
Q3 2021 Jul 21, 2025	SELL	$25.04 - $30.06 $5,408 - $6,492	-216 Reduced 1.03%	20,807 $580 Million
Q2 2021 Jul 21, 2025	BUY	$27.43 - $32.7 $20,325 - $24,230	741 Added 3.65%	21,023 $617 Million
Q1 2021 Jul 21, 2025	BUY	$21.37 - $34.38 $19,639 - $31,595	919 Added 4.75%	20,282 $643 Million
Q4 2020 Jul 21, 2025	BUY	$15.31 - $21.12 $120,305 - $165,960	7,858 Added 68.3%	19,363 $402 Million
Q3 2020 Jul 21, 2025	BUY	$14.88 - $20.13 $28,524 - $38,589	1,917 Added 19.99%	11,505 $179 Million
Q2 2020 Jul 21, 2025	BUY	$13.31 - $20.51 $127,616 - $196,649	9,588 New	9,588 $175 Million

253

240M

2.46M

8.42M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.39B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Credential Qtrade Securities Inc., based on Form 13F filings with the SEC.

Stay updated on Credential Qtrade Securities Inc. with notifications on news.